LumiThera Closes Series C Round of Financing – LumiThera US
SEATTLE, July 8, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed its Series C financing. The company raised approximately $14M to support further commercialization of its Valeda Light Delivery System for the treatment for dry …
LumiThera Closes Series C Round of Financing – LumiThera US Read More »